Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-16 5:10 pm Purchase | 2022-12-31 | 13G | ACUITYADS HLDGS INC ILLM | K2 PRINCIPAL FUND L.P. | 3,198,531 5.630% | 350,415 (+12.30%) | Filing History |
| 2023-03-16 5:06 pm Purchase | 2022-08-12 | 13G | ACUITYADS HLDGS INC ILLM | K2 PRINCIPAL FUND L.P. | 2,848,116 5.010% | 2,848,116 (New Position) | Filing History |
| 2023-02-13 4:48 pm Purchase | 2023-01-26 | 13G | San Juan Basin Royalty Trust SJT | K2 PRINCIPAL FUND L.P. | 2,367,933 5.080% | 1,061,124 (+81.20%) | Filing History |
| 2023-02-13 4:43 pm Sale | 2022-12-31 | 13G | San Juan Basin Royalty Trust SJT | K2 PRINCIPAL FUND L.P. | 1,306,809 2.800% | -1,033,159 (-44.15%) | Filing History |
| 2023-02-13 4:39 pm Sale | 2022-12-31 | 13G | Solid Biosciences Inc. SLDB | K2 PRINCIPAL FUND L.P. | 284,871 1.460% | -95,742 (-25.15%) | Filing History |
| 2023-02-13 4:32 pm Purchase | 2022-12-31 | 13G | ARS Pharmaceuticals, Inc. SPRY | K2 PRINCIPAL FUND L.P. | 2,045,348 2.200% | 138,730 (+7.28%) | Filing History |
| 2023-02-08 5:51 pm Sale | 2022-12-31 | 13G | TCR2 Therapeutics Inc. TCRR | K2 PRINCIPAL FUND L.P. | 0 0.000% | -1,950,628 (Position Closed) | Filing History |
| 2023-02-08 5:22 pm Sale | 2022-12-31 | 13G | Goldenstone Acquisition Limited GDSTU | K2 PRINCIPAL FUND L.P. | 0 0.000% | -375,000 (Position Closed) | Filing History |
| 2023-02-08 5:21 pm Unchanged | 2022-12-31 | 13G | Sagaliam Acquisition Corp. SAGA | K2 PRINCIPAL FUND L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-08 5:06 pm Unchanged | 2022-12-31 | 13G | Relativity Acquisition Corp. RACY | K2 PRINCIPAL FUND L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-07 7:00 pm Sale | 2022-12-31 | 13G | AVROBIO, Inc. AVRO | K2 PRINCIPAL FUND L.P. | 0 0.000% | -186,322 (Position Closed) | Filing History |
| 2022-08-31 6:13 pm Purchase | 2022-08-26 | 13G | TCR2 Therapeutics Inc. TCRR | K2 PRINCIPAL FUND L.P. | 1,950,628 5.050% | 1,950,628 (New Position) | Filing History |
| 2022-08-31 5:49 pm Purchase | 2022-08-29 | 13G | Solid Biosciences Inc. SLDB | K2 PRINCIPAL FUND L.P. | 380,613 5.050% | 380,613 (New Position) | Filing History |
| 2022-07-29 6:57 pm Purchase | 2022-07-28 | 13G | AVROBIO, Inc. AVRO | K2 PRINCIPAL FUND L.P. | 186,322 5.120% | 186,322 (New Position) | Filing History |
| 2022-07-15 6:03 pm Purchase | 2022-07-13 | 13G | ARS Pharmaceuticals, Inc. SPRY | K2 PRINCIPAL FUND L.P. | 1,906,618 5.410% | 1,906,618 (New Position) | Filing History |
| 2022-03-22 5:08 pm Purchase | 2022-03-17 | 13G | Goldenstone Acquisition Limited GDSTU | K2 PRINCIPAL FUND L.P. | 375,000 5.660% | 375,000 (New Position) | Filing History |
| 2022-02-16 5:00 pm Purchase | 2022-02-10 | 13G | Relativity Acquisition Corp. RACYU | K2 PRINCIPAL FUND L.P. | 670,000 5.360% | 670,000 (New Position) | Filing History |
| 2022-01-31 6:21 pm Sale | 2021-12-31 | 13G | Pasithea Therapeutics Corp. KTTA | K2 PRINCIPAL FUND L.P. | 54,721 4.990% | -30,279 (-35.62%) | Filing History |
| 2022-01-27 6:54 pm Sale | 2021-12-31 | 13G | Welsbach Technology Metals Acquisition Corp. WTMAU | K2 PRINCIPAL FUND L.P. | 436,100 4.490% | -63,900 (-12.78%) | Filing History |
| 2022-01-26 5:25 pm Sale | 2022-01-25 | 13G | Ignyte Acquisition Corp. IGNY | K2 PRINCIPAL FUND L.P. | 259,958 3.570% | -152,693 (-37.00%) | Filing History |